U.S. Markets close in 2 hrs 36 mins

Novogen Limited (NVGN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.9000+0.0500 (+1.7544%)
As of 1:18PM EDT. Market open.
People also watch
Full screen
Previous Close2.8500
Bid2.7500 x 100
Ask2.9000 x 10000
Day's Range2.8028 - 2.9000
52 Week Range0.7000 - 3.5000
Avg. Volume29,152
Market Cap55.39M
PE Ratio (TTM)-5.27
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Yahoo Finance4 months ago

    Democrats found a way to speak Trump's language in pharma debate

    The members of congress introduced a bill related to the talk last week. A quartet of Democratic members of Congress introduced a bill last week in harmony with President Donald Trump’s campaign promises of lowering prescription drug costs. Entitled the Improving Access to Affordable Prescription Drugs Act, the 128-page bill aims to overhaul what many view as a broken system that has seen bipartisan outrage over skyrocketing prices.

  • Benzinga4 months ago

    Novogen Receives $4.4M R&D Tax Rebate

    Novogen Ltd (NASDAQ: NVGN ) is pleased to confirm receipt of $4.4m from the Australian Taxation Office under the R&D Tax Incentive Program for the financial year ending 30 June 2016. These funds will be ...

  • Benzinga9 months ago

    Novogen Licenses Phase II-ready Molecule from Genentech for Development in Glioblastoma for $5M Upfront , Plus Milestones

    Novogen Ltd (NASDAQ: NVGN ) today announced that it has entered into a worldwide licensing agreement with Genentech, a member of the Roche Group (OTC: RHHBY ), to develop and commercialise GDC-0084, a ...